Business Description
Intervacc AB
ISIN : SE0009607252
Compare
Compare
Traded in other countries / regions
IVACC.Sweden2E9.Germany IPO Date
2022-05-16Description
Intervacc AB is a biotechnology company. It develops new vaccines based on recombinant proteins to meet the increasing need for effective vaccines in animal health care. The company through its subsidiary focuses on diagnostics in the Swedish animal health market and offers bacteriological and mycological analyses on the Swedish market.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 272.36 | |||||
| Equity-to-Asset | 0.88 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 0.88 | |||||
| Beneish M-Score | -1.83 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 6.4 | |||||
| 3-Year EBITDA Growth Rate | -35.1 | |||||
| 3-Year EPS without NRI Growth Rate | -50.2 | |||||
| 3-Year FCF Growth Rate | -3 | |||||
| 3-Year Book Growth Rate | -18.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 30.88 | |||||
| Future 3-5Y Total Revenue Growth Rate | 144.21 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 7.18 | |||||
| 9-Day RSI | 14.5 | |||||
| 14-Day RSI | 21.07 | |||||
| 6-1 Month Momentum % | -24.54 | |||||
| 12-1 Month Momentum % | -62.88 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.6 | |||||
| Quick Ratio | 2.26 | |||||
| Cash Ratio | 2.01 | |||||
| Days Inventory | 283.35 | |||||
| Days Sales Outstanding | 25.31 | |||||
| Days Payable | 230.38 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -9.5 | |||||
| Shareholder Yield % | 0.19 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -43.01 | |||||
| Operating Margin % | -857.15 | |||||
| Net Margin % | -832.82 | |||||
| FCF Margin % | -530.9 | |||||
| ROE % | -35.17 | |||||
| ROA % | -32.06 | |||||
| ROIC % | -46.8 | |||||
| ROC (Joel Greenblatt) % | -8434.79 | |||||
| ROCE % | -35.16 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 8.2 | |||||
| PB Ratio | 0.42 | |||||
| Price-to-Tangible-Book | 1.62 | |||||
| EV-to-EBIT | 0.18 | |||||
| EV-to-Forward-EBIT | -3.88 | |||||
| EV-to-EBITDA | 0.25 | |||||
| EV-to-Forward-EBITDA | -5.63 | |||||
| EV-to-Revenue | -1.54 | |||||
| EV-to-Forward-Revenue | 4.69 | |||||
| EV-to-FCF | 0.25 | |||||
| Price-to-Net-Current-Asset-Value | 1.62 | |||||
| Price-to-Net-Cash | 2.7 | |||||
| Earnings Yield (Greenblatt) % | 542.98 | |||||
| FCF Yield % | -66.86 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Intervacc AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.822 | ||
| EPS (TTM) (€) | -0.09 | ||
| Beta | 0 | ||
| Volatility % | 48.35 | ||
| 14-Day RSI | 21.07 | ||
| 14-Day ATR (€) | 0.011087 | ||
| 20-Day SMA (€) | 0.163445 | ||
| 12-1 Month Momentum % | -62.88 | ||
| 52-Week Range (€) | 0.0811 - 0.554 | ||
| Shares Outstanding (Mil) | 75.74 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Intervacc AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Intervacc AB Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Intervacc AB Frequently Asked Questions
What is Intervacc AB(STU:2E9)'s stock price today?
The current price of STU:2E9 is €0.08. The 52 week high of STU:2E9 is €0.55 and 52 week low is €0.08.
When is next earnings date of Intervacc AB(STU:2E9)?
The next earnings date of Intervacc AB(STU:2E9) is 2025-02-13.
Does Intervacc AB(STU:2E9) pay dividends? If so, how much?
Intervacc AB(STU:2E9) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers